Work

A phase I study of niraparib in combination with temozolomide (TMZ) in patients with advanced cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2092

Authors: Razelle Kurzrock, Evanthia Galanis, Derek Richard Johnson, Vikram Kansra, Keith Wilcoxen, Ty Mcclure, Robert E. Martell, Shefali Agarwal

Institutions: University of California San Diego, Mayo Clinic, Tesaro (United States)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2625407327

Cites:

Cited by: 13

Related to: 10